ACM
JSPRW icon

Altium Capital Management’s Japer Therapeutics Warrants JSPRW Stock Holding History

Altium Capital Management’s Portfolio JSPRW Stock Details JSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-162,500
Closed -$133K – 146
2021
Q1 		$133K Hold
162,500
– – 0.04% 122
2020
Q4 		$236K Buy
+162,500
New +$204K 0.09% 88

Other funds holding JSPRW

OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $445M AUM 2.55% 1-Year Est. Return

Altium Capital Management's JSPRW Position: Q2 2021 in Review

Altium Capital Management sold out of Japer Therapeutics Warrants (JSPRW) in Q2 2021, closing a stake of 162,500 shares — an estimated $133K sold.

Altium Capital Management first reported a position in JSPRW in Q4 2020 and held it in 2 quarters. The position peaked at $236K in Q4 2020. 20 funds tracked by Wall St. Rank hold JSPRW as of Q2 2021.

  • Altium Capital Management reported no remaining Japer Therapeutics Warrants position as of Q2 2021 after selling out during the quarter.
  • Altium Capital Management sold 162,500 Japer Therapeutics Warrants shares in Q2 2021, an estimated $133K.
  • Altium Capital Management first reported a position in Japer Therapeutics Warrants in Q4 2020 and held it in 2 quarters.
  • Altium Capital Management's Japer Therapeutics Warrants position peaked at $236K in Q4 2020.
  • 20 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q2 2021.

Based on Altium Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.